Providence Medical Technology

What Providence Medical Technology does

Providence Medical Technology, Inc. is a privately held medical device company founded in 2008 and headquartered in Pleasanton, California, that develops tissue-sparing instrumentation and implants for posterior cervical and lumbar spinal fusion. The company's core technology platform, the CORUS Spinal System, comprises sterile-packaged single-use instruments for facet joint access, bone preparation, decortication, and graft delivery, paired with implants including CORUS PCSS (Posterior Cervical Stabilization System) for up to 3-level cervical fusion, CORUS-LX for 1- and 2-level lumbar fusion, CAVUX cervical cages and facet fixation systems, ALLY bone screws, ENTRUS allograft bone, and the DiViNE Portal System for tissue-sparing visualization. The company has secured FDA 510(k) clearance across the portfolio, including a landmark 2024 clearance of CORUS PCSS for 3-level cervical degenerative disc disease based on a Level 1 IDE study (the FUSE Study) that was published in the journal Spine in September 2025.

The business model is a traditional Class III medical device hardware sales motion: Providence sells sterile, single-use spinal fusion devices and instruments through a dedicated U.S. direct sales force targeting spine surgeons, neurosurgeons, and hospitals, with cumulative utilization across 2,600+ approved hospital facilities, 2,300+ trained surgeons, and 21,000+ surgical cases. The company monetizes primarily through the CORUS Navigation Access System (compatible with Medtronic StealthStation and Globus Medical ExcelsiusGPS robotics platforms), partner-enabled reimbursement support via PRIA Healthcare, and surgeon training programs that drive adoption of the differentiated tissue-sparing approach.

Providence has reported 40% revenue growth in both 2024 and 2025 alongside two consecutive years of positive EBITDA, funded by approximately $101 million of disclosed equity and debt financing since 2008 across investors including MVM Life Science Partners, Aphelion Capital, Revelation Partners, Medvest Capital, Silicon Valley Bank, Bridge Bank, BMO Global Asset Management, and Armentum Partners. Management includes Co-founder/CEO Jeff Smith, Co-founder Dr. Bruce McCormack, COO Edward Liou, CFO Brian Mower, Chief Product Officer Scott Lynch, and Chief Commercial Officer Jim Hens (appointed February 2026 from Silony Spine/NuVasive), with a board chaired by Art Taylor of Monterey Advisors. The strategic posture entering 2026 is one of evidence-driven commercial scaling: leveraging the FUSE Study publication to drive deeper penetration of cervical fusion while extending the CORUS platform into the lumbar market via a parallel randomized controlled trial.

Name

Providence Medical Technology

Legal name

Providence Medical Technology, Inc.

Website

https://providencemt.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Providence Medical Technology is a privately-held medical device company that develops tissue-sparing posterior spinal fusion systems (CORUS platform) for cervical and lumbar procedures, selling sterile single-use implants and instruments through a direct U.S. field sales force to spine surgeons and hospitals.

Ownership category

akta.pro rank

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Spinal fusion devices
• Cervical spine implants
• Posterior fixation systems
• Orthopedic surgical instruments
• Lumbar fusion technology

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

Revenue model

1. Medical Device Sales: Sale of spinal fusion devices and surgical instruments including CORUS Spinal System, CORUS PCSS, CORUS-LX, CAVUX cages, ALLY screws, and ENTRUS allograft bone. Products are sterile-packaged and single-use.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Providence Medical Technology designs, manufactures, and sells tissue-sparing spinal fusion medical devices for posterior cervical and lumbar procedures. Its product portfolio centers on the CORUS technology platform and includes the CORUS Spinal System (sterile, single-use instruments for access, bone preparation, decortication, and implant delivery), CORUS PCSS for circumferential cervical fusion, CORUS-LX for lumbar fusion, CAVUX cervical cages and facet fixation systems, ALLY bone screws, ENTRUS allograft bone, the DiViNE portal system, and navigation-compatible access instruments that integrate with Medtronic StealthStation and Globus Medical ExcelsiusGPS platforms.

Product overview

Providence Medical Technology is a medical device company offering tissue-sparing spinal fusion solutions centered on the CORUS technology platform. The portfolio includes the CORUS Spinal System (instruments for cervical and lumbar fusion access and preparation), CORUS PCSS (Posterior Cervical Stabilization System for circumferential cervical fusion up to 3 levels), CORUS-LX (lumbar fusion system), and CAVUX cervical cages and facet fixation systems. Supporting products include the ALLY Bone Screw, ENTRUS Allograft Bone, and DiViNE Portal System for visualization. The company also offers navigation-compatible versions (CORUS Navigation Access System) integrating with Medtronic StealthStation and Globus Medical ExcelsiusGPS platforms. All instruments are sterile-packaged and single-use.

Differentiator

Problem solved

Functional benefit

Brands

• CORUS: Spinal system for posterior cervical and lumbar fusion, including PCSS (Posterior Cervical Stabilization System) and CORUS-LX for lumbar applications.
• CAVUX
• ALLY
• ENTRUS
• DiViNE

Quantifiable outcome

• 61% composite fusion success rate vs 17% for ACDF alone at 12 months (3-level CCF vs ACDF)
• +4 more outcomes

Named customers3 records

Segments3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and supporting.

• Globus Medical (ExcelsiusGPS)coreTechnology or Integration · 9 December 2025CORUS-GLX System compatibility with Globus Medical's ExcelsiusGPS Robotic Navigation Platform enables robotic-assisted posterior lumbar fusion surgery with enhanced precision and workflow efficiency.
• Medtronic (StealthStation)coreTechnology or Integration · 13 June 2024CORUS Navigation Access System received FDA clearance for use with Medtronic StealthStation surgical navigation system for posterior spinal fusion procedures. The system enables enhanced accuracy, precision, and visualization when utilizing CORUS instruments and spinal implants.
• PRIA HealthcaresupportingImplementation/ SI/ Consulting PartnerPRIA Healthcare provides reimbursement support services for Providence's trained physicians, including preauthorization requests, appeal requests, claim appeals, and real-time case updates through a secure online portal.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Globus Medical: One of the largest spine device companies (now includes NuVasive) with broad cervical and lumbar fusion portfolios and the ExcelsiusGPS robotic platform that CORUS-GLX integrates with. Directly competes in cervical/lumbar fusion and is both a competitor and integration partner.
• Medtronic (Spine & Biologics): Global spine leader whose StealthStation surgical navigation system CORUS integrates with. Medtronic competes across anterior/posterior cervical fusion, interbody devices, and biologics, making it a primary commercial competitor and strategic partner.
• Stryker (Spine division): Diversified medtech incumbent with a growing spine and navigation portfolio. Competes in cervical and lumbar fusion instrumentation and is expanding its surgical navigation/robotics offering into the same OR footprint as CORUS.

Direct peers

• Alphatec Holdings (ATEC): Pure-play spine company focused on cervical and thoracolumbar fusion, with a similar surgeon-driven, clinical-evidence-led GTM motion. Direct competitor in cervical fusion and a comparable public-market benchmark for growth-stage spine companies.
• Orthofix Medical: Spine and orthopedics device company with cervical and lumbar fusion products. Direct competitor in the same surgeon customer base, with overlapping posterior cervical and lumbar fusion indications.

Emerging players

• Centinel Spine: Privately held spine company specializing in cervical disc replacement and fusion. Directly competes in the cervical spine segment with surgeon-focused clinical evidence and a similar specialty positioning.
• Life Spine: Privately held spine device company offering cervical and lumbar fusion solutions with a focus on micro-invasive approaches. Competes with Providence in the posterior cervical and lumbar fusion segments.
• SI-BONE: Public spine company that expanded from sacroiliac joint fusion into adjacent lumbar fusion indications. Comparable growth-stage spine pure-play with a similar surgeon-training-led adoption model.
• Silony Medical / Silony Spine: European-headquartered spine company with a growing U.S. presence in posterior cervical and lumbar fixation. Recent prior employer of Providence's new CCO, indicating direct overlap in product categories and surgeon customer base.
• Aurora Spine: Small-cap spine device company focused on minimally invasive cervical and lumbar fusion. Competes in similar fusion indications and represents a comparable specialty spine pure-play at the lower end of the market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dtrax_facet
• LinkedInlinkedin.com/company/providence-medical-technology-inc.

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds9 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Providence Medical Technology